Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas.
Saved in:
| Title: | Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas. |
|---|---|
| Authors: | Pemov A; Clinical Genetics Branch, DCEG, NCI, National Institutes of Health (NIH), Rockville, Maryland, USA., Hansen NF; Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, NIH, Rockville, Maryland, USA., Sindiri S; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Patidar R; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA.; Molecular Characterization & Clinical Assay Development Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc, Frederick, Maryland, USA., Higham CS; Children's National Medical Center, Washington, DC, USA.; Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Dombi E; Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Miettinen MM; Laboratory of Pathology, NCI, NIH, Bethesda, Maryland, USA., Fetsch P; Laboratory of Pathology, NCI, NIH, Bethesda, Maryland, USA., Brems H; Department of Human Genetics, Catholic University Leuven, Leuven, Belgium., Chandrasekharappa SC; Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, NIH, Rockville, Maryland, USA., Jones K; Cancer Genomics Research Laboratory, DCEG, NIH, Rockville, Maryland, USA., Zhu B; Cancer Genomics Research Laboratory, DCEG, NIH, Rockville, Maryland, USA., Wei JS; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Mullikin JC; Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, NIH, Rockville, Maryland, USA.; NISC, National Human Genome Research Institute, NIH, Rockville, Maryland, USA., Wallace MR; Department of Molecular Genetics and Microbiology, UF Genetics Institute, UF Health Cancer Center, University of Florida, Gainesville, Florida, USA., Khan J; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Legius E; Department of Human Genetics, Catholic University Leuven, Leuven, Belgium., Widemann BC; Pediatric Oncology Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, USA., Stewart DR; Clinical Genetics Branch, DCEG, NCI, National Institutes of Health (NIH), Rockville, Maryland, USA. |
| Corporate Authors: | National Intramural Sequencing Center (NISC) Comparative Sequencing Program, National Cancer Institute (NCI) Division of Cancer Epidemiology and Genetics (DCEG) Cancer Genomics Research Laboratory |
| Source: | Neuro-oncology [Neuro Oncol] 2019 Aug 05; Vol. 21 (8), pp. 981-992. |
| Publication Type: | Journal Article; Meta-Analysis; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noz028 |
